ACMSD: A Novel Target for Modulating NAD+ Homeostasis
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference10 articles.
1. Therapeutic potential of NAD-boosting molecules: the in vivo evidence;Rajman;Cell Metab.,2018
2. NAD(+) intermediates: the biology and therapeutic potential of NMN and NR;Yoshino;Cell Metab.,2018
3. The pharmacology of CD38/NADase: an emerging target in cancer and diseases of aging;Chini;Trends Pharmacol. Sci.,2018
4. De novo NAD(+) biosynthetic impairment in acute kidney injury in humans;Poyan Mehr;Nat. Med.,2018
5. Alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase controls dietary niacin requirements for NAD(+) synthesis;Palzer;Cell Rep.,2018
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dietary nicotinic acid promotes the growth and tryptophan metabolome of Chinese mitten crab (Eriocheir sinensis) through ACMSD and NADs;Aquaculture Reports;2023-12
2. ACMSD mediated de novo NAD+ biosynthetic impairment in cardiac endothelial cells as a potential therapeutic target for diabetic cardiomyopathy;Diabetes Research and Clinical Practice;2023-12
3. Camel whey protein improves diabetic liver injury by targeting ACMSD and promoting de novo NAD+ synthesis;Journal of Functional Foods;2023-11
4. Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD;Nano Research;2023-04-18
5. The Profiles and Functions of RNA Editing Sites Associated with High-Altitude Adaptation in Goats;International Journal of Molecular Sciences;2023-02-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3